Biomarkers of the metabolic syndrome and breast cancer prognosis

Qiu Li Zhu, Wang Hong Xu, Meng Hua Tao

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

In spite of its public health importance, our understanding of the mechanisms of breast carcinogenesis and progress is still evolving. The metabolic syndrome (MS) is a constellation of biochemical abnormalities including visceral adiposity, hyperglycemia, hyperinsulinemia, dyslipidemia and high blood pressure. The components of the MS have all been related to late-stage disease and even to a poor prognosis of breast cancer through multiple interacting mechanisms. In this review, we aim to present a summary of recent advances in the understanding of the contribution of the MS to breast cancer with the emphasis on the role of biomarkers of the MS in the prognosis of breast cancer.

Original languageEnglish
Pages (from-to)721-739
Number of pages19
JournalCancers
Volume2
Issue number2
DOIs
StatePublished - 1 Jun 2010

Fingerprint

Biomarkers
Breast Neoplasms
Adiposity
Hyperinsulinism
Dyslipidemias
Hyperglycemia
Carcinogenesis
Breast
Public Health
Hypertension

Keywords

  • Biomarkers
  • Breast cancer
  • Epidemiology
  • Metabolic syndrome
  • Prognosis

Cite this

Zhu, Qiu Li ; Xu, Wang Hong ; Tao, Meng Hua. / Biomarkers of the metabolic syndrome and breast cancer prognosis. In: Cancers. 2010 ; Vol. 2, No. 2. pp. 721-739.
@article{ff8f6beb2c044bbea58c3e1dcfb83de2,
title = "Biomarkers of the metabolic syndrome and breast cancer prognosis",
abstract = "In spite of its public health importance, our understanding of the mechanisms of breast carcinogenesis and progress is still evolving. The metabolic syndrome (MS) is a constellation of biochemical abnormalities including visceral adiposity, hyperglycemia, hyperinsulinemia, dyslipidemia and high blood pressure. The components of the MS have all been related to late-stage disease and even to a poor prognosis of breast cancer through multiple interacting mechanisms. In this review, we aim to present a summary of recent advances in the understanding of the contribution of the MS to breast cancer with the emphasis on the role of biomarkers of the MS in the prognosis of breast cancer.",
keywords = "Biomarkers, Breast cancer, Epidemiology, Metabolic syndrome, Prognosis",
author = "Zhu, {Qiu Li} and Xu, {Wang Hong} and Tao, {Meng Hua}",
year = "2010",
month = "6",
day = "1",
doi = "10.3390/cancers2020721",
language = "English",
volume = "2",
pages = "721--739",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",

}

Biomarkers of the metabolic syndrome and breast cancer prognosis. / Zhu, Qiu Li; Xu, Wang Hong; Tao, Meng Hua.

In: Cancers, Vol. 2, No. 2, 01.06.2010, p. 721-739.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Biomarkers of the metabolic syndrome and breast cancer prognosis

AU - Zhu, Qiu Li

AU - Xu, Wang Hong

AU - Tao, Meng Hua

PY - 2010/6/1

Y1 - 2010/6/1

N2 - In spite of its public health importance, our understanding of the mechanisms of breast carcinogenesis and progress is still evolving. The metabolic syndrome (MS) is a constellation of biochemical abnormalities including visceral adiposity, hyperglycemia, hyperinsulinemia, dyslipidemia and high blood pressure. The components of the MS have all been related to late-stage disease and even to a poor prognosis of breast cancer through multiple interacting mechanisms. In this review, we aim to present a summary of recent advances in the understanding of the contribution of the MS to breast cancer with the emphasis on the role of biomarkers of the MS in the prognosis of breast cancer.

AB - In spite of its public health importance, our understanding of the mechanisms of breast carcinogenesis and progress is still evolving. The metabolic syndrome (MS) is a constellation of biochemical abnormalities including visceral adiposity, hyperglycemia, hyperinsulinemia, dyslipidemia and high blood pressure. The components of the MS have all been related to late-stage disease and even to a poor prognosis of breast cancer through multiple interacting mechanisms. In this review, we aim to present a summary of recent advances in the understanding of the contribution of the MS to breast cancer with the emphasis on the role of biomarkers of the MS in the prognosis of breast cancer.

KW - Biomarkers

KW - Breast cancer

KW - Epidemiology

KW - Metabolic syndrome

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=79952265935&partnerID=8YFLogxK

U2 - 10.3390/cancers2020721

DO - 10.3390/cancers2020721

M3 - Review article

AN - SCOPUS:79952265935

VL - 2

SP - 721

EP - 739

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 2

ER -